These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 30532035)

  • 1. Simpotentin, a new potentiator of amphotericin B activity against Candida albicans, produced by Simplicillium minatense FKI-4981.
    Uchida R; Kondo A; Yagi A; Nonaka K; Masuma R; Kobayashi K; Tomoda H
    J Antibiot (Tokyo); 2019 Mar; 72(3):134-140. PubMed ID: 30532035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nectriatide, a Potentiator of Amphotericin B Activity from
    Fukuda T; Nagai K; Yagi A; Kobayashi K; Uchida R; Yasuhara T; Tomoda H
    J Nat Prod; 2019 Oct; 82(10):2673-2681. PubMed ID: 31498627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Total Synthesis and Absolute Configuration of Simpotentin, a Potentiator of Amphotericin B Activity.
    Ohtawa M; Shimizu E; Saito A; Sakamoto S; Waki A; Kondo A; Yagi A; Uchida R; Tomoda H; Nagamitsu T
    Org Lett; 2019 Jul; 21(14):5596-5599. PubMed ID: 31246478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined in vitro activity of amphotericin B and 5-fluorocytosine against Cryptococcus neoformans and Candida albicans.
    Chen HH; Liushih RN; Hsieh WC
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1982 May; 15(2):106-12. PubMed ID: 7047097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of antifungal antibiotics on some determinants of virulence in Candida albicans and Cryptococcus neoformans cells.
    Borowski J; Jakoniuk P; Jablońska W; Jakubicz W; Szpak A
    Experientia; 1974 Oct; 30(10):1210-1. PubMed ID: 4611784
    [No Abstract]   [Full Text] [Related]  

  • 6. 6'-Hydroxy-3'-methoxy-mitorubrin, a new potentiator of antifungal miconazole activity, produced by Penicillium radicum FKI-3765-2.
    Yamazaki H; Omura S; Tomoda H
    Chem Pharm Bull (Tokyo); 2010 Jun; 58(6):829-32. PubMed ID: 20522994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro synergic antifungal effect of MUC7 12-mer with histatin-5 12-mer or miconazole.
    Wei GX; Bobek LA
    J Antimicrob Chemother; 2004 May; 53(5):750-8. PubMed ID: 15073161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tensidols, new potentiators of antifungal miconazole activity, produced by Aspergillus niger FKI-2342.
    Fukuda T; Hasegawa Y; Hagimori K; Yamaguchi Y; Masuma R; Tomoda H; Omura S
    J Antibiot (Tokyo); 2006 Aug; 59(8):480-5. PubMed ID: 17080684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Off-Patent Drugs That Show Synergism with Amphotericin B or That Present Antifungal Action against Cryptococcus neoformans and
    Rossi SA; de Oliveira HC; Agreda-Mellon D; Lucio J; Mendes-Giannini MJS; García-Cambero JP; Zaragoza O
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31988099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Funicone-related compounds, potentiators of antifungal miconazole activity, produced by Talaromycesflavus FKI-0076.
    Arai M; Tomoda H; Okuda T; Wang H; Tabata N; Masuma R; Yamaguchi Y; Omura S
    J Antibiot (Tokyo); 2002 Feb; 55(2):172-80. PubMed ID: 12002999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro determination of optimal antifungal combinations against Cryptococcus neoformans and Candida albicans.
    Ghannoum MA; Fu Y; Ibrahim AS; Mortara LA; Shafiq MC; Edwards JE; Criddle RS
    Antimicrob Agents Chemother; 1995 Nov; 39(11):2459-65. PubMed ID: 8585726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Asperfurandiones A and B, two antifungal furandione analogs from a marine-derived fungus
    Ding L; Xu P; Li T; Liao X; He S; Xu S
    Nat Prod Res; 2019 Dec; 33(23):3404-3408. PubMed ID: 29806501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polyketide glycosides phialotides A to H, new potentiators of amphotericin B activity, produced by Pseudophialophora sp. BF-0158.
    Yagi A; Uchida R; Kobayashi K; Tomoda H
    J Antibiot (Tokyo); 2020 Apr; 73(4):211-223. PubMed ID: 31974520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-vitro activity of cilofungin (LY121019) in comparison with amphotericin B.
    Meunier F; Lambert C; Van der Auwera P
    J Antimicrob Chemother; 1989 Sep; 24(3):325-31. PubMed ID: 2681118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of amphotericin B and flucytosine in combination against Candida albicans and Cryptococcus neoformans using time-kill methodology.
    Keele DJ; DeLallo VC; Lewis RE; Ernst EJ; Klepser ME
    Diagn Microbiol Infect Dis; 2001 Nov; 41(3):121-6. PubMed ID: 11750164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The antiproliferative peptide Ctn[15-34] is active against multidrug-resistant yeasts Candida albicans and Cryptococcus neoformans.
    de Aguiar FLL; Cavalcante CSDP; Dos Santos Fontenelle RO; Falcão CB; Andreu D; Rádis-Baptista G
    J Appl Microbiol; 2020 Feb; 128(2):414-425. PubMed ID: 31626724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potentiation of rifampicin and 5-fluorocytosine as antifungal antibiotics by amphotericin B (yeast-membrane permeability-ribosomal RNA-eukaryotic cell-synergism).
    Medoff G; Kobayashi GS; Kwan CN; Schlessinger D; Venkov P
    Proc Natl Acad Sci U S A; 1972 Jan; 69(1):196-9. PubMed ID: 4550505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of voriconazole and amphotericin B against Candida albicans, Candida krusei, and Cryptococcus neoformans in human cerebrospinal fluid.
    Al Jalali V; Sauermann R; Eberl S; Zeitlinger M
    Infection; 2019 Aug; 47(4):565-570. PubMed ID: 30725316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acetylenic acids inhibiting azole-resistant Candida albicans from Pentagonia gigantifolia.
    Li XC; Jacob MR; ElSohly HN; Nagle DG; Smillie TJ; Walker LA; Clark AM
    J Nat Prod; 2003 Aug; 66(8):1132-5. PubMed ID: 12932143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced activity of antifungal drugs using natural phenolics against yeast strains of Candida and Cryptococcus.
    Faria NC; Kim JH; Gonçalves LA; Martins Mde L; Chan KL; Campbell BC
    Lett Appl Microbiol; 2011 May; 52(5):506-13. PubMed ID: 21332761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.